Skip to content

Insider · CIK 0001509688

Dean L Schorno

cfoofficer

Files at RIGL (RIGEL PHARMACEUTICALS INC). First filing -, latest -.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 1, 2026RIGL
RIGEL PHARMACEUTICALS INC
FTax withholding
Common Stock
-928$47.50$44k78,36239 d ago
Sep 2, 2026RIGL
RIGEL PHARMACEUTICALS INC
MOption exercise
Common Stock
+694$12.70$8,81479,05639 d ago
Sep 2, 2026RIGL
RIGEL PHARMACEUTICALS INC
MOption exercise
Common Stock
+620$18.70$12k79,67639 d ago
Sep 2, 2026RIGL
RIGEL PHARMACEUTICALS INC
MOption exercise
Common Stock
+2,000$24.20$48k81,67639 d ago
Sep 2, 2026RIGL
RIGEL PHARMACEUTICALS INC
MOption exercise
Common Stock
+1,286$24.20$31k82,96239 d ago
Sep 2, 2026RIGL
RIGEL PHARMACEUTICALS INC
MOption exercise
Employee Stock Option (right to buy)derivative
-694$0.00$012,82439 d ago
Sep 2, 2026RIGL
RIGEL PHARMACEUTICALS INC
MOption exercise
Employee Stock Option (right to buy)derivative
-620$0.00$09,01239 d ago
Sep 2, 2026RIGL
RIGEL PHARMACEUTICALS INC
MOption exercise
Employee Stock Option (right to buy)derivative
-2,000$0.00$07,99939 d ago
Sep 2, 2026RIGL
RIGEL PHARMACEUTICALS INC
MOption exercise
Employee Stock Option (right to buy)derivative
-1,286$0.00$015,86739 d ago
Sep 15, 2025RIGL
RIGEL PHARMACEUTICALS INC
AGrant or award
Employee Stock Option (right to buy)derivative
+7,394$0.00$07,394Sep 17, 2025
Nov 25, 2024RIGL
RIGEL PHARMACEUTICALS INC
AGrant or award
Employee Stock Option (right to buy)derivative
+6,250$0.00$06,250Nov 26, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Dean L Schorno: insider trades and track record | InsiderTell